Sorry, you need to enable JavaScript to visit this website.
Skip to main content
 

Search

Debra J. Rasmussen

Debra J. Rasmussen

Debra J. Rasmussen supports regulatory affairs for Janssen Diagnostics. In this role, she is responsible for development of regulatory strategy, policy and registration of the in vitro diagnostic devices associated with Johnson & Johnson drug development and commercialization. For Janssen, both companion and complementary diagnostics and mobile medical applications regulatory strategy and expertise are driven by the Global Regulatory Affairs Diagnostics group.

Deb’s regulatory and quality career has spanned both large and small companies and both United States and global programs. She has been in diagnostics for more than 25 years and gained her experience working at Bio-Rad Laboratories, Roche Molecular Systems, Chiron Corporation (now Novartis), Applied Imaging Corporation and Visible Genetics. She holds an M.B.A. from St. Mary’s College in Maryland and a Bachelor of Science degree in Bacteriology/Immunology from the University of California, Berkeley.